机构风向标 | 创新医疗(002173)2025年二季度已披露前十大机构持股比例合计下跌4.25个百分点

Core Viewpoint - Innovation Medical (002173.SZ) reported its 2025 semi-annual results, indicating a decrease in institutional investor holdings compared to the previous quarter [1] Institutional Holdings - As of August 8, 2025, five institutional investors disclosed holdings in Innovation Medical A-shares, totaling 41.4963 million shares, which represents 9.40% of the total share capital [1] - The institutional investor group includes Shanghai Guanghuan Technology Co., Ltd., Hangzhou Changjian Investment Partnership (Limited Partnership), BARCLAYS BANK PLC, Goldman Sachs International - Proprietary Capital, and BNP Paribas - Proprietary Capital [1] - The total institutional holding percentage decreased by 4.25 percentage points compared to the previous quarter [1] Foreign Investment - One foreign fund, BARCLAYS BANK PLC, increased its holdings in this period, accounting for a 0.19% increase [1] - A new foreign institution disclosed this quarter is Goldman Sachs International - Proprietary Capital [1] - The foreign institution that did not disclose its holdings this quarter is MORGAN STANLEY & CO. INTERNATIONAL PLC [1]